The full BEVA Congress programme is now live and super early bird tickets are available from 4th March, saving member delegates up to £200.
The one medicine thread will run through the medicine and orthopaedics and sports medicine streams as well as feature in the Peter Rossdale Plenary Lecture.
BEVA President Roger Smith said “There is much to learn from the human side as well as from what we do as vets.
"We have invited five human medical experts to make some comparative links with human medicine in their presentations.
"Bringing a different angle in this way will help predict what the future holds and advance what we do in the equine veterinary sphere.”
The full programme includes more than 90 hours of live and on-demand CPD covering almost every aspect of equine medicine, surgery and practice.
The first day will commence with an opening address from Olympic gold medallist Sally Gunnell during which she will share her thoughts on maximising performance.
Other highlights include:
Individual super early bird BEVA members prices are £524 for vets and £144 for vet nurses for all three days (with concessionary available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Super early bird ends on Wednesday 29 May 2024.
www.bevacongress.org
Despite being a common disease, CVS says very little research has been undertaken into EPD in the UK.
In addition, numerous different treatments are currently used for EPD, for which there is not always robust scientific evidence.
The CVS study, which started in 2022 and will continue till early 2024, involves 20 practices.
Samples have been collected from over 70 cases from horses that have been diagnosed by EPD throughout the UK.
Full blood profiles have been assessed, in addition to bacterial culture analysis of the lesions, PCR analysis for dermatophytes (ringworm fungi), microscopy for ectoparasites (mites) and skin cytology.
An owner questionnaire has also been completed to gather information on EDP management.
Each horse’s lesions have been graded and descriptive data relating to the lesions were recorded.
Data collection is now complete and a team of researchers, led by vet Manuela Diaz Ramos, has started analysing the data.
A full report on the findings, along with treatment and management recommendations, is expected to be presented at a scientific conference later this year.
Pergocoat contains pergolide, a long-acting dopamine receptor agonist.
It is available in 0.5mg (off-white) and 1mg (yellow) tablets for accurate dosing without the need to split tablets.
The tablets are film-coated to mask the bitter taste of pergolide and create a barrier between the horse owner and the active ingredient.
Available in two different pack sizes containing 60 or 160 tablets, Pergocoat tablets are packaged in double layered blister packs to help minimise the risk of accidental ingestion.
Rachel Addison BVM&S MRCVS, equine field support manager at Dechra said: “Pergocoat is available in two convenient tablet sizes to achieve an optimal treatment response.
"Horses can be monitored and reviewed every four to six weeks until stabilisation or improvement of clinical signs is observed.”
https://www.dechra.co.uk/products/horse/prescription/pergocoat#Pergocoat-0-5mg-60-film-coated-tablets-for-horses.
The survey of 2717 horse owners, 56% of which were leisure owners and 35% professionals, found that most horses (62%) were retired between 15-24 years of age, mainly for health reasons.
Mares had a higher risk of retirement than geldings, which the researchers say may be due in part to mares used for breeding not doing much structured exercise.
Just over 1 in 6 horses in the study were affected by low muscle mass according to their owners.
Age, sex, osteoarthritis, laminitis, pituitary pars intermedia dysfunction (PPID), and primary use were identified as risk factors for low muscle mass.
Geldings had a higher risk of low muscle mass than mares, which the researchers say may be a result of low testosterone.
Horses with owner-reported veterinary-diagnosed PPID, osteoarthritis and laminitis had a higher risk of low muscle mass.
Primary use was identified as a risk factor for low muscle mass, with retired horses having a higher risk than horses used for competition or pleasure riding.
Owner-reported low muscle mass was perceived to affect welfare and the ability to work in the majority of senior horses.
Alisa Herbst, who led the study, said: “A prolonged working/active life may not only be desired by owners but is also likely to provide health and welfare benefits to the horse.
"We hope the results of this study may be useful for veterinarians caring for senior and geriatric equines, by helping to achieve this."
“The information may aid in the investigation of diseases affecting senior horses and in establishing senior horse-owner education programs.
"The low muscle mass risk factor list may assist vets in identifying horses at risk of low muscle mass to be selected for close monitoring.
“Vets may also consider inclusion of an objective measurement of muscle atrophy, such as the muscle atrophy scoring system (MASS)***, in annual wellness exams, so that atrophy can be identified and managed as early as possible."
Sarah Nelson, Product Manager at Mars Horsecare added: “This survey has highlighted several interesting retirement trends.
“With a better understanding of when and why senior horses are being retired we hope, eventually, to be better placed to monitor for, prevent (where possible), and treat the underlying conditions early on, to help horses stay active and healthy for longer.”
https://www.seniorhorsehealth.com
Reference
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
The survey of 50 vets carried out in May this year1 found that only half of them are recommending strangles vaccination to their clients.
They also felt that horse owners could be doing more to combat the disease.
Less than half of vets questioned believed that yards and premises operated good biosecurity measures prior to a strangles outbreak, yet 85% brought in more stringent biosecurity after an outbreak, when it was too late.
Dechra says that vets and horse owners can help combat the estimated 300 outbreaks of strangles each year with the following steps:
Sara Barker BVSc CertAVP(EM) MRCVS, equine field support manager at Dechra, said: “Strangles is one of the most common equine infectious diseases both in the UK and worldwide and a multi-factor approach is key to tackling the disease.
"Strangles vaccination is recommended, alongside good biosecurity, quarantine measures and regular temperature checking.
"By working together, vets and horse owners can help to keep horses healthy and prevent the spread of strangles.”
The new packaging uses fewer plastic components and a new cardboard box.
Sabrina Jordan, Virbac’s Equine Product Manager said: "The new cardboard component is a substantial step forward making the new packaging more environmentally friendly."
She added: "This new Equimax packaging has a fresh new look and is now available at wholesalers."
Vets with Horsepower is organised annually by Professor Derek Knottenbelt to help raise funds for equine and human charities around the world.
This year the group undertook an endurance motorbike trip of over 1600 miles: from the UK to Germany, across Scandinavia and back, hosting education events for equine vets along the way to raise funds for four charities including BEVA's Power for Ukraine.
BEVA Council member Alison Talbot, said: “Thanks to the generosity of equine vets in the UK we had just hit the halfway mark of raising £10,000, before Vets with Horsepower set off on their epic Scandinavian mission.
"We are so grateful for their donation of £9922 which means we can now buy another five generators, to help twice as many vets and horses in extremely difficult circumstances during enforced power cuts."
The generators will be transported to a collection point in Poland and then on to Ukraine in time for winter.
Donations to the BEVA Trust Power To Ukraine appeal can be made here: https://www.justgiving.com/campaign/powertoukraine
Any surplus funds will be added to the general fund to support equids in Ukraine.
Preliminary results, which recorded a decline in the quantities of antimicrobials prescribed from 2014 to 2018, were published in 2022.
A further audit has now been undertaken in all 22 of the company's first opinion practices to investigate the age, breed and estimated weight of each horse, the clinical indication for antibiotic use, the drugs prescribed, their dose rates, the route of administration and whether culture and sensitivity were used to guide antimicrobial selection.
Data collection was completed in August 2022.
This secondary audit was conducted using a ‘point prevalence’ survey, in which each CVS Equine first opinion Quality Improvement Lead gathered information about all systemic antibiotics prescribed by each of their practices on one day a month for 12 consecutive months.
The project yielded information on 331 cases where systemic antimicrobials were prescribed.
Complete data about the first line-drug selection were available for 261 prescriptions.
The commonest prescribed antimicrobial was sulfadiazine/trimethoprim (41%), followed by oxytetracycline (23%), procaine penicillin (16%), doxycycline (13%), gentamicin (4%), metronidazole (1%), ceftiofur (1%) and enrofloxacin (1%).
Highest priority critically important antimicrobials (ceftiofur and enrofloxacin) were only prescribed in four horses (clinical indications for these included possible sepsis, skin infection, lower respiratory tract infection and a wound complication – in none of these cases was the first-line drug selection based on the results of culture and sensitivity.
Overall, the clinical indications for antimicrobial use were recorded in 246 cases; the commonest indications were cellulitis/lymphangitis (27%), uncomplicated wounds (19%), surgical prophylaxis (15%), respiratory infections (11%) and skin infections (8%).
Hattie Lawrence, Director of CVS Equine, said: “Though the impact of this work is yet to be documented, there is anecdotal evidence that it has raised awareness amongst our veterinarians of the importance of antimicrobial stewardship.
"Taken together, the results of both pieces of work will be used to help develop and inform clinical audits and clinical guidelines of antimicrobial use in horses.”
Thus far, the hospital has relied on conventional radiographs or referred for MRI for the bulk of its distal limb imaging.
The new Hallmarq standing CT scanner provides information that surpasses the capabilities of radiography, while also reducing radiation exposure to the patients and staff.
The scanning process is also considerably quicker, enabling prompt diagnosis and treatment planning.
Tom McParland, Valley Equine Hospital’s surgeon said: "We are confident that this diagnostic modality will significantly enhance our ability to identify not just thoroughbred fetlock pathology earlier but improve our diagnostic abilities of the distal limb for all our equine patients, racing and leisure alike.”
Valley Equine Hospital says it chose the Hallmarq standing CT scanner due to its ability to scan using just standing sedation which ensures a safer and more efficient experience for the horses compared to general anaesthesia.
www.valleyequinehospital.co.ukinfo.hallmarq.net/focus-on-the-foot
The event is held every four years and hosted alternately by BEVA and the American Association of Equine Practitioners (AAEP).
It offers the opportunity for equine vets to absorb and digest the latest knowledge, clinical practice and scientific advances in the treatment and prevention of colic, from the world’s leading international equine gastroenterology experts.
Held over 2.5 days, the symposium comprises numerous 12-minute oral presentations on a range of topics including surgical techniques, treatment, parasitology, gastric ulceration, endotoxemia, pharmacology of intestinal motility, colic complications, epidemiology, physiology of digestion, the intestinal microbiome and metabolomics.
Each session will be followed by three minutes for questions and discussion.
Poster sessions on the first two days will cover ground beyond the oral presentations and delegates will be able to review and discuss the work with presenters.
There will also be opportunities to network with other equine vets, researchers and professionals.
Clinicians and scientists have until 1 February 2024 to submit abstracts of recent work that they wish to present at this meeting.
The scientific committee will consider abstracts on all aspects of equine gastroenterology, including basic science research and reports of clinical cases or novel approaches to treatment.
The abstract submission form is here: https://form.jotform.com/230473925626359
Tickets cost £475 (with a concessionary rate of £235 for post graduate students and interns) and includes a drinks reception on both 10th & 11th, an evening buffet and Ceilidh on 11th and lunch on 11th & 12th.
Further information and booking details can be found here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1740
The survey will assess vets’ experiences of the disease, biosecurity and the role of vaccination to help prevent strangles.
It includes questions on the number of strangles cases diagnosed in the last year, how the diagnosis was reached and in what instances they would recommend strangles vaccination.
The survey, which is approximately two minutes long, is at: https://forms.office.com/e/wH1UeVFmVW.
All participants will be entered into a prize draw for a £50 Amazon voucher.
For further information on Strangles Awareness Week: https://www.redwings.org.uk/strangles/strangles-awareness-week.
Jonathon is an RCVS & EBVS European Specialist in Veterinary Diagnostic Imaging, with a particular interest in MRI of the distal limb and has published scientific work on this subject, among others.
With the increase in availability and accessibility to CT for horses, VetCT says this hot topic will be well received by equine vets at all levels of experience.
VetCT’s Equine Teleradiology Manager, Charlotte Graham, said: “We can guarantee a highly engaging talk with plenty of useful tips on case selection for each modality as well as some interesting discussions in the Q&A session.”
To register for the webinar on 18th April and receive links to recordings of this and previous webinars in the 2023 series, sign up here: https://vetct.zoom.us/webinar/register/WN_zkctYZYWRUmRVIFTxrvvsA
www.vet-ct.com
The DC heard that Mr Hutton had attended to a horse called Angel at a livery yard in Sheffield.
As he examined the horse, it kicked Mr Hutton in the leg, whereupon he kicked it back in the abdomen.
Mr Hutton admitted the facts of the allegation against him.
The Committee noted that there was a dispute between the parties about the exact manner in which the kick had been administered and whether the conduct amounted to disgraceful conduct.
Both the College and the defence obtained the opinion of experts, who were not in agreement as to whether the conduct amounted to serious professional misconduct.
The Committee heard evidence from Angel’s owner, Ms A, who was present when Mr Hutton kicked Angel and from Ms B, Mr Hutton’s life partner, who was also present.
In his witness statement, Mr Hutton said that his kick “was an instinctive reaction to what had happened and an instinctive reprimand for what I felt in the aftermath of the kick from her was malicious behaviour”.
Mr Hutton also stated that the reprimand was an appropriate response which a horse would understand, in order to modify its future behaviour.
In the hearing, Mr Hutton apologised for the incident with Angel. He said it had happened in the heat of the moment. He wished that he had apologised straight away.
In his expert evidence before the Committee, Mr T Gliddon MRCVS, called by the College, agreed that attitudes to physical reprimands had changed over time.
In his expert report, he stated that a reprimand administered by a veterinary surgeon that may have been considered acceptable by a significant body of the veterinary profession some decades ago would no longer be regarded as such now, in his opinion.
In re-examination, he stated that in his opinion, there was not a reasonable body of veterinary opinion which would consider kicking a horse as an acceptable form of negative reinforcement of behaviour.
In his expert evidence to the Committee, Dr H Tremaine FRCVS, called by Mr Hutton, stated that in the case of the minority of veterinary surgeons who used physical reprimands as a means of modifying behaviour, he was not aware that such reprimands would include the use of a kick.
The Committee concluded from the evidence that, following the kick from Angel, Mr Hutton moved away from the horse, so that he was no longer in immediate danger and that his kick in response had come after a gap in time, albeit brief.
Ms Greaney, Counsel for the College, provided written submissions on serious professional misconduct, submitting that principles 1.1 (Veterinary surgeons must make animal health and welfare their first consideration when attending to animals) and 6.5 (Veterinary surgeons must not engage in any activity or behaviour that would be likely to bring the profession into disrepute or undermine public confidence in the profession) of the Code of Professional Conduct had been breached.
It was submitted that, on the basis that there had been a deliberate decision by Mr Hutton to kick Angel in the abdomen, he had time to consider his actions.
The College submitted that deliberately kicking Angel, either as punishment or by way of teaching or training a horse, fell far below the standard expected of veterinary surgeons.
The Committee found Mr Hutton’s state of mind when kicking Angel was not an issue and that Mr Hutton had intentionally kicked the horse.
In reaching its decision in relation to whether Mr Hutton’s conduct amounted to serious professional misconduct the Committee took into account that:
Mrs Judith Way, chairing the Committee and speaking on its behalf, said: “The Committee determined that taking all circumstances and its findings into account, this conduct was a single, but serious failure on the part of Mr Hutton and found the facts proved amounted to disgraceful conduct in a professional respect.
“On deciding what, if any, sanction ought to be imposed, the Committee considered the aggravating and mitigating factors of the case, based on findings at the earlier stages of the hearing.
"The Committee found that there had been a risk of physical and/or mental injury to Angel from Mr Hutton’s conduct but accepted that there were a number of mitigating factors.
“It had been found that the incident had occurred over a very brief period and that Mr Hutton had not taken proper time to consider his response to Angel’s unexpected kick.
"This was found to be a single isolated incident and the character evidence indicated that otherwise, Mr Hutton was a competent and well-regarded veterinary surgeon.
"Mr Hutton admitted the kick early on in the proceedings and had issued an early apology, albeit seeking initially to raise some justification for his actions.
“The Committee was persuaded, in light of Mr Hutton’s admissions, heartfelt apologies, developing insight and the testimonial evidence, that he is very unlikely to repeat his past misconduct.
"However, despite the low risk of repetition, the Committee considered that the nature of the kick, delivered without the consent of the owner, could undermine public confidence in the profession.
"Thus, the Committee considered that it was proportionate to issue a reprimand together with a warning as to Mr Hutton’s future conduct.
"It has determined that this would be proportionate and sufficient to provide adequate protection for animals and maintain public confidence in the profession.”
The full details of the hearing and the Committee’s decision can be found at www.rcvs.org.uk/disciplinary.
Membra is a transparent, water-resistant, non-toxic, biodegradable bandage replacement consisting of a hydrogel polymer which can be applied to open wounds.
It is initially applied as a liquid and quickly gels into a thin, flexible layer over the site.
The initial liquid phase of Membra allows it to cover open and irregular spaces as well as suture lines and it dries in minutes to form a barrier that covers and protects the incision site or wound.
Being transparent, Membra allows the wound to be seen by the veterinary team and pet owners.
Membra lasts for up to 14 days and naturally biodegrades over time.
Animus says that Membra lowers the risk of infection or dehiscence.
The company also says that hydrogel polymer has been shown to replace the need for adhesive bandaging on suture lines following major TPLO surgery.
A study concluded that the polymer did not appear to raise the prevalence of incisional complications after TPLO surgery and lasts for 14 days, rather than 24-48 hours with traditional bandaging1.
Nick Butcher MRCVS, owner of Animus Surgical in the UK, said: “Regular bandaging of open wounds can be costly, time-consuming and stressful for owners and their pets, requiring frequent visits to the practice.
"The bandaging of some open wounds can be impossible because of the location of the lesion or the affected species (e.g. exotic or aquatic animals) and more aggressive or nervous patients may require sedation.
"Used bandages also add to the volume of clinical waste generated by the practice which requires incineration
“We are therefore delighted to launch Membra to veterinary teams in the UK.
"It has been very successful in the U.S. and we already have a number of UK vets using the product as Membra can positively affect the outcome of open wound management across a range of species, without the need for regular bandage changes.”
To find out how to apply Membra, a range of YouTube videos are available showing a selection of case examples: https://youtube.com/@sutureseal5917.
www.animussurgical.com.
The current inventory of Equip Artervac has an expiry date of March 29, 2023 and the company is not expecting a new batch to be available until the end of September 2023.
Zoetis says it has been working with relevant organisations to implement a plan to mitigate the impact on breeders.
The Thoroughbred Breeders Association has published advice for a blood sampling scheme at: https://www.rossdales.com/news-events/tba-members-equine-vaccine-advice-regarding-disruption-to-supply-of-equip-artervac, but Zoetis highlights that the advice requires action two weeks after the most recent EVA vaccination.
For more information contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0345 300 8034
"Advances in Imaging of the Equine Distal Limb 2017–2022" comprises a total of 20 papers which have been selected by Mathieu Spriet, Ann Carstens and Tim Mair.
It also includes an editorial from the EVJ summarising the major historical technological developments in imaging of the foot and fetlock.
The publication looks at the evolution of computed tomography (CT), positron emission tomography (PET), which has opened a whole new field of possibilities for bone and soft tissue imaging in racehorses and sport horses, MRI and how it has been improved by optimising scanning techniques, ultrasound radiography and scintigraphy.
Mathieu Spriet said: “The content of this virtual issue represents an amazing amount of new knowledge that with no doubt will contribute to improve equine welfare and safety.
“With the increase availability and versatility of all the imaging modalities, the knowledge base appears to increase exponentially.
"We are very excited to see what the next five years will bring. We hope the readers will enjoy consulting this collection as much as we enjoyed putting it together.”
The virtual issue is free for 12 weeks and can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.equine-distal-limb
Photo: 18F-NaF PET, CT and MRI images from a horse with navicular and middle phalanx lesions. Adapted from EVJ 2018;50: 125-132
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
The article argues that as the equine influenza (EI) vaccine supply returns to normal, there is sound scientific evidence why bi-annual vaccination schedules should be re-implemented promptly.
Whilst the scale and number of outbreaks has been relatively small since the introduction of mandatory EI vaccination by most competitive equestrian disciplines in the 1980s, disease events such as those experienced in the UK in 1989, 2003 and most recently in 2019 have demonstrated EI’s epidemic potential, even in vaccinated horse populations.
In their article 'Equine influenza bi-annual boosters: what does the evidence tell us?' Victoria Colgate and Richard Newton discuss what has been learnt from previous outbreaks and explain the evidence from mathematical models to show why bi-annual boosters are beneficial.
The authors say that epidemiological data from previous natural EI outbreaks have repeatedly demonstrated the impermanent nature of the protection provided by vaccination and observational field studies have repeatedly highlighted the potential for 12-monthly boosters to leave a vulnerable immunity gap at both the individual animal and population level.
Mathematical models of EI transmission confirm that six-monthly rather than annual EI booster vaccinations are preferable to establish and maintain effective population level immunity to EI.
Ideally vaccine strains should be updated in a timely manner to ensure inclusion of the most epidemiologically-relevant strains, however, this is a slow and expensive process for equine vaccine manufacturers.
In the absence of updated vaccine strains, bi-annual vaccination is strongly recommended to help compensate for antigenic drift between vaccine and circulating EI viral strains
Professor Celia Marr, Editor of the EVJ said: “Although the recent EI vaccine shortage has necessitated a temporary relaxation of competition vaccine schedules, we must now renew the message that six-monthly boosters are optimal and necessary.”
The Editorial can be found at https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13898 and is free to view.
Two related articles can be found here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13874 and here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13885
Bruce Bladon will describe current antibiotic use in equine practice, Victoria South will consider the use of Highest Priority Critically Important Antimicrobials, and Bettina Dunkel will describe strategies to reduce antimicrobial use.
The webinar is free for both members and non-members.
To register, visit: https://us02web.zoom.us/webinar/register/7016678281618/WN__XNTbcxoQ2K1mXUGOIVL_g
Photo: Safia Barakzai, Equine Surgeon
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
At 9.00am on Thursday and 1.45pm on Friday, Dr Sam Taylor, Feline Specialist and academy lead at the International Society of Feline Medicine (ISFM), will present ‘feline pawsative’, a talk about about cat inappetence and the remedy offered by Mirataz.
At 11.20am on Thursday and 9.00am on Friday, Matt Gurney, clinical director at Anderson Moores will be sharing the latest developments in sedation in dogs including Zenalpha.
At 12.30pm on Thursday and 12.35pm on Friday, Andrew Waller (pictured right), chief scientific officer at Intervacc AB, will be discussing how to rein in the impact of strangles using Dechra’s new protein-based vaccine, Strangvac.
The CPD sessions are first come, first served, and Dechra says it expects the presentations to be well-attended, so it could be worth getting there a little early, although probably no need to pitch a tent outside the night before.
The webinar will take place at 11am and will be repeated at 7.30pm for those who are unable to listen during the day.
Hosted by Zoetis vet Dr Wendy Talbot the session will last for approximately an hour and equates to 8 AMTRA CPD points.
Wendy will explain the current situation and recommended approaches to help slow resistance.
The webinar will conclude with a live Q&A to give everyone the opportunity to discuss any queries, concerns or common questions they hear from their customers with Wendy.
Zoetis Equine Product Manager, Penny McCann said: "Our webinars continue to be very well received.
“This one is particularly important as it explains the important new thinking around the use of anthelmintics in order to address the serious challenge of resistance.
"It’s a must for all those involved with prescribing.”
To book the 11am webinar: https://register.gotowebinar.com/register/6163460189961597967 To book the 7.30pm webinar: https://register.gotowebinar.com/register/6394015684169009164